Evidence map›Paper›PMID 23157252›Full record

ArticleJournal of the American Chemical Society2012

Tetarimycin A, an MRSA-active antibiotic identified through induced expression of environmental DNA gene clusters.

Dimitris Kallifidas, Hahk-Soo Kang, Sean F Brady

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. An unusual aromatase/cyclase programs the formation of the phenyldimethylanthrone framework in anthrabenzoxocinones and fasamycin.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Review
  5. Mining metagenomes reveals diverse antibiotic biosynthetic genes in uncultured microbial communities.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in microbiology · 2022
    Review
  14. Article
  15. Review
  16. Heterologous expression-facilitated natural products' discovery in actinomycetes.Journal of industrial microbiology & biotechnology · 2019
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Dimitris KallifidasLaboratory of Genetically Encoded Small Molecules, The Rockefeller University, Howard Hughes Medical Institute, 1230 York Avenue, New York, New York 10065, United States.
Hahk-Soo Kang
Sean F Brady
Howard Hughes Medical Institute · USRockefeller University · US

Funding

Discovery and characterization of new natural products from uncultured bacteriaR01GM077516 · NIGMS · ROCKEFELLER UNIVERSITY · PI BRADY, SEAN F · 2006 to 2014
$3.0M
Howard Hughes Medical InstituteNIGMS NIH HHS GM077516NIGMS NIH HHS R01 GM077516
6 · The paper itself

Abstract

The propagation of DNA extracted directly from environmental samples in laboratory-grown bacteria provides a means to study natural products encoded in the genomes of uncultured bacteria. However, gene silencing often hampers the functional characterization of gene clusters captured on environmental DNA clones. Here we show that the overexpression of transcription factors found in sequenced environmental DNA-derived biosynthetic gene clusters, in conjunction with traditional culture-broth extract screening, can be used to identify new bioactive secondary metabolites from otherwise-silent gene clusters. Tetarimycin A, a tetracyclic methicillin-resistant Staphylococcus aureus (MRSA)-active antibiotic, was isolated from the culture-broth extract of Streptomyces albus cultures cotransformed with an environmentally derived type-II polyketide biosynthetic gene cluster and its pathway-specific Streptomyces antibiotic regulatory protein (SARP) cloned under the control of the constitutive ermE* promoter.

Indexed as

Methicillin-Resistant Staphylococcus aureusMultigene FamilyAnti-Bacterial AgentsBacteriaBase SequenceCloning, MolecularMicrobial Sensitivity TestsModels, MolecularMolecular Sequence DataPhylogenyPolycyclic CompoundsStaphylococcus aureusAnti-Bacterial AgentsPolycyclic Compoundstetarimycin A

Identifiers

PMID23157252
PMCPMC3540986
OpenAlexW2047932269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.